AtriCure Return on Investment 2010-2024 | ATRC
Current and historical return on investment (ROI) values for AtriCure (ATRC) over the last 10 years.
| AtriCure ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-06-30 | $-0.04B | $0.54B | -6.59% |
| 2024-03-31 | $-0.03B | $0.53B | -6.07% |
| 2023-12-31 | $-0.03B | $0.54B | -5.16% |
| 2023-09-30 | $-0.02B | $0.52B | -4.23% |
| 2023-06-30 | $-0.03B | $0.52B | -4.81% |
| 2023-03-31 | $-0.04B | $0.52B | -6.71% |
| 2022-12-31 | $-0.04B | $0.52B | -8.18% |
| 2022-09-30 | $-0.05B | $0.52B | -9.75% |
| 2022-06-30 | $0.06B | $0.53B | 10.70% |
| 2022-03-31 | $0.06B | $0.53B | 10.96% |
| 2021-12-31 | $0.06B | $0.55B | 11.01% |
| 2021-09-30 | $0.05B | $0.56B | 10.41% |
| 2021-06-30 | $-0.05B | $0.44B | -11.48% |
| 2021-03-31 | $-0.05B | $0.45B | -9.53% |
| 2020-12-31 | $-0.04B | $0.48B | -10.14% |
| 2020-09-30 | $-0.04B | $0.48B | -10.40% |
| 2020-06-30 | $-0.05B | $0.48B | -12.89% |
| 2020-03-31 | $-0.04B | $0.30B | -14.08% |
| 2019-12-31 | $-0.03B | $0.32B | -10.92% |
| 2019-09-30 | $-0.02B | $0.33B | -7.08% |
| 2019-06-30 | $-0.02B | $0.28B | -6.71% |
| 2019-03-31 | $-0.01B | $0.28B | -5.16% |
| 2018-12-31 | $-0.02B | $0.30B | -7.32% |
| 2018-09-30 | $-0.02B | $0.22B | -7.71% |
| 2018-06-30 | $-0.02B | $0.21B | -8.44% |
| 2018-03-31 | $-0.02B | $0.21B | -12.17% |
| 2017-12-31 | $-0.03B | $0.20B | -12.82% |
| 2017-09-30 | $-0.03B | $0.19B | -15.74% |
| 2017-06-30 | $-0.03B | $0.20B | -14.83% |
| 2017-03-31 | $-0.03B | $0.20B | -15.44% |
| 2016-12-31 | $-0.03B | $0.21B | -14.98% |
| 2016-09-30 | $-0.03B | $0.21B | -16.55% |
| 2016-06-30 | $-0.03B | $0.22B | -18.48% |
| 2016-03-31 | $-0.03B | $0.20B | -19.08% |
| 2015-12-31 | $-0.03B | $0.20B | -18.49% |
| 2015-09-30 | $-0.02B | $0.13B | -16.25% |
| 2015-06-30 | $-0.02B | $0.13B | -12.17% |
| 2015-03-31 | $-0.01B | $0.13B | -10.55% |
| 2014-12-31 | $-0.02B | $0.13B | -12.69% |
| 2014-09-30 | $-0.02B | $0.14B | -14.17% |
| 2014-06-30 | $-0.02B | $0.13B | -19.69% |
| 2014-03-31 | $-0.02B | $0.13B | -24.32% |
| 2013-12-31 | $-0.01B | $0.08B | -23.30% |
| 2013-09-30 | $-0.01B | $0.04B | -24.32% |
| 2013-06-30 | $-0.01B | $0.04B | -28.35% |
| 2013-03-31 | $-0.01B | $0.04B | -30.48% |
| 2012-12-31 | $-0.01B | $0.02B | -33.33% |
| 2012-09-30 | $-0.01B | $0.02B | -32.56% |
| 2012-06-30 | $-0.01B | $0.02B | -22.99% |
| 2012-03-31 | $-0.01B | $0.02B | -22.73% |
| 2011-12-31 | $-0.01B | $0.02B | -22.99% |
| 2011-09-30 | $-0.00B | $0.02B | -14.46% |
| 2011-06-30 | $-0.00B | $0.02B | -15.19% |
| 2011-03-31 | $-0.00B | $0.02B | -10.96% |
| 2010-12-31 | $-0.00B | $0.02B | -17.39% |
| 2010-09-30 | $-0.01B | $0.02B | -27.78% |
| 2010-06-30 | $-0.01B | $0.02B | -42.11% |
| 2010-03-31 | $-0.01B | $0.02B | -42.35% |
| 2009-12-31 | $-0.02B | $0.02B | -67.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.384B | $0.399B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.139B | 25.33 |
| Stryker (SYK) | United States | $137.702B | 32.18 |
| Boston Scientific (BSX) | United States | $122.346B | 37.26 |
| Medtronic (MDT) | Ireland | $114.719B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.985B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.286B | 35.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.218B | 0.00 |
| ResMed (RMD) | United States | $35.640B | 31.38 |
| Koninklijke Philips (PHG) | Netherlands | $29.674B | 22.55 |
| Terumo (TRUMY) | Japan | $28.204B | 39.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.935B | 13.81 |
| Baxter (BAX) | United States | $19.749B | 13.39 |
| Insulet (PODD) | United States | $16.507B | 69.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.465B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.256B | 30.67 |
| Demant (WILYY) | Denmark | $8.667B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.864B | 33.25 |
| Lantheus Holdings (LNTH) | United States | $7.251B | 17.41 |
| ICU Medical (ICUI) | United States | $4.262B | 40.67 |
| Haemonetics (HAE) | United States | $3.918B | 19.38 |
| Neogen (NEOG) | United States | $3.612B | 37.89 |
| TG Therapeutics (TGTX) | United States | $3.612B | 38.25 |
| GN Store Nord (GNNDY) | Denmark | $3.576B | 21.54 |
| Prestige Consumer Healthcare (PBH) | United States | $3.536B | 17.62 |
| Perrigo (PRGO) | Ireland | $3.496B | 11.05 |
| Envista Holdings (NVST) | United States | $3.310B | 17.66 |
| QuidelOrtho (QDEL) | United States | $2.970B | 18.72 |
| Agios Pharmaceuticals (AGIO) | United States | $2.734B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.220B | 37.25 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.109B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.029B | 54.07 |
| Warby Parker (WRBY) | United States | $1.620B | 0.00 |
| InMode (INMD) | Israel | $1.444B | 9.19 |
| AdaptHealth (AHCO) | United States | $1.385B | 10.00 |
| Owens & Minor (OMI) | United States | $1.213B | 9.36 |
| Verano Holdings (VRNOF) | United States | $1.199B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.115B | 0.00 |
| Evolus (EOLS) | United States | $1.032B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.29 |
| Phibro Animal Health (PAHC) | United States | $0.895B | 18.57 |
| National Vision Holdings (EYE) | United States | $0.852B | 27.10 |
| Cresco Labs (CRLBF) | United States | $0.820B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 116.58 |
| Quanterix (QTRX) | United States | $0.498B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.483B | 14.57 |
| ZimVie (ZIMV) | United States | $0.430B | 39.97 |
| Valneva SE (VALN) | France | $0.425B | 0.00 |
| Jin Medical (ZJYL) | China | $0.422B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.397B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.386B | 0.00 |
| Cerus (CERS) | United States | $0.330B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.318B | 8.19 |
| Aurora Cannabis (ACB) | Canada | $0.314B | 0.00 |
| Biote (BTMD) | United States | $0.295B | 13.62 |
| Viemed Healthcare (VMD) | United States | $0.281B | 30.17 |
| Zynex (ZYXI) | United States | $0.262B | 45.89 |
| Sanara MedTech (SMTI) | United States | $0.254B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.233B | 15.45 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| MacroGenics (MGNX) | United States | $0.191B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.157B | 65.00 |
| FitLife Brands (FTLF) | United States | $0.152B | 20.55 |
| Brainsway (BWAY) | Israel | $0.137B | 164.20 |
| TriSalus Life Sciences (TLSI) | United States | $0.122B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.117B | 0.00 |
| Veru (VERU) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.112B | 11.39 |
| Jushi Holdings (JUSHF) | United States | $0.105B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 24.00 |
| Zevia PBC (ZVIA) | United States | $0.085B | 0.00 |
| InterCure (INCR) | Israel | $0.083B | 14.08 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Modular Medical (MODD) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.068B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Exagen (XGN) | United States | $0.055B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.44 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 21.89 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |